News search
Research 29 May 2025 CNIC researchers have discovered that the heart is formed from two independent cell types that act in synchrony from the onset of gastrulation. This finding could help to better understand the origin of certain congenital heart defects and open up new opportunities in regenerative medicine and tissue bioengineering. |
Research 17 May 2025 Dra. Maria Kontaridis currently serves as the Gordon K. Moe Professor and Chair of Biomedical Research and Translational Medicine, as well as is the Executive Director and Director of Research, at the Masonic Medical Research Institute |
Research 14 May 2025 Jianyi «Jay» Zhang, Chair of the Department of Biomedical Engineering (BME), at University of Alabama -Birmingham (UAB). |
Research 14 Apr 2025 A study led by the Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), in collaboration with the Instituto de Investigación Biomédica de Barcelona (IRB Barcelona), has identified the most effective subtype of dendritic cell for generating immune memory in response to cancer |
About the CNIC 8 Apr 2025 The system provides specialised answers to biomedical questions, ensuring data privacy by operating exclusively within the CNIC |
Research 19 Mar 2025 The discovery, published in Nature, opens the path to new strategies for treating skin diseases and immunological disorders, with special potential for the treatment of inflammation, diabetes, and age-related conditions |
About the CNIC 15 Jan 2025 The study describes an innovative probe for the noninvasive detection of macrophages using PET technology |
Research 12 Dec 2024 iFlpMosaics is a new technology presented in Nature Methods that allows the modification and study of gene function in mouse models, advancing research on diseases caused by somatic mutations, such as cancer and vascular malformations. |
Research 28 Nov 2024 A study from the CNIC, published in Nature Communications, reveals how caveolae allow adipocytes to expand safely, storing fat without breaking or causing inflammation |
Research 30 Aug 2024 Two studies carried out at the CNIC provide key information about a newly identified cardiovascular risk factor, clonal hematopoiesis, and its treatment with the ancient medication colchicine |
- 1 of 8
- next ›